WHO Euro/ASPHER and has been member of the past GLOHRA Steering Board. Her research focuses on comparative health policy, the health workforce, and gender equality/SDG5 from an intersectional perspective
intervention is evaluated on the basis of the summarizing analysis of the application experiences the comparative analysis of selected quality indicators of end-of-life care (see above) and interviews with relatives
with mistletoe extracts in patients with breast cancer as an adjunct to conventional cancer therapy compared to conventional cancer therapy alone. Medical efficacy and safety, costs and cost-effectiveness
narrowing in the area of the isthmus. Nevertheless, after successful correction, life expectancy is comparable to that of the normal population and everyday life is usually possible without restrictions.
can be prepared precisely. The use of dual-source technology further reduces radiation exposure compared to conventional CT systems. By integrating the 3D CT data sets obtained in this way into the planning
ology and Intensive Care Medicine has restructured the training period in order to guarantee a comparable, excellent level of both professional and social skills, which are indispensable for the medical
medical assistant. We offer you training at a university hospital with an excellent reputation comparatively high remuneration (in accordance with the TVL-BBiG collective agreement) interdisciplinary training
the market. Objective To determine the degree of agreement between the results of the respective comparable measurement approaches (fibrinogen clot, approach, extrinsic approach and intrinsic approach with [...] study was conducted together with the Hematology and Trauma Surgery departments with the aim of comparing different hemostaseological examinations in patients with severe polytrauma (ISS > 15). For this
produce anti-inflammatory messenger substances after stimulation with the bacterium Escherichia coli. Compared to MAIT cells obtained from the blood of the same patients, this response was higher, demonstrating
safety of daily intravenous alteplase treatment given up to 5 days on top of standard of care (SOC) compared with SOC alone, in patients with acute respiratory distress syndrome (ARDS) triggered by COVID-19